Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Midwest Clinical Research Center
mi
from
Dayton, OH
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Oklahoma Clinical Research Center
mi
from
Oklahoma City, OK
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Oklahoma Clinical Research Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Lehigh Center for Clinical Research
mi
from
Allentown, PA
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Lehigh Center for Clinical Research
mi
from
Allentown, PA
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Belmont Center for Comprehensive Treatment
mi
from
Philadelphia, PA
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Belmont Center for Comprehensive Treatment
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
University of Pittsburgh Medical Center (UPMC)
mi
from
Pittsburgh, PA
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
University of Pittsburgh Medical Center (UPMC)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Carolina Clinical Trials, Inc.
mi
from
Charleston, SC
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Carolina Clinical Trials, Inc.
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
FutureSearch Clinical Trials LP
mi
from
Austin, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
FutureSearch Clinical Trials LP
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Pillar Clinical Research, LLC
mi
from
Dallas, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
InSite Clinical Resesearch
mi
from
DeSoto, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
InSite Clinical Resesearch
mi
from
DeSoto, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
InSite Clinical Research LLC
mi
from
DeSoto, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
InSite Clinical Research LLC
mi
from
DeSoto, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Fein-Jennings Clinic, Inc.
mi
from
Houston, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Fein-Jennings Clinic, Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Claghorn-Lesem Research Clinic
mi
from
Houston, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Claghorn-Lesem Research Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Clinical Trial Network
mi
from
Houston, TX
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Clinical Trial Network
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Lifetree Clinical Research
mi
from
Salt Lake City, UT
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Lifetree Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Birmingham Psychiatry Pharmaceutical Studies, Inc.
mi
from
Birmingham, AL
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Birmingham Psychiatry Pharmaceutical Studies, Inc.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Collaborative Neuro Science Network, Inc.
mi
from
Garden Grove, CA
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Collaborative Neuro Science Network, Inc.
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Stanford -VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Stanford -VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders
mi
from
Boston, MA
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders
mi
from
Boston, MA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
St Charles Psychiatric Associates - Midwest Research Group
mi
from
St. Charles, MO
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
St Charles Psychiatric Associates - Midwest Research Group
mi
from
St. Charles, MO
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Village Clinical Research Inc.
mi
from
New York, NY
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Village Clinical Research Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Finger Lakes Clinical Research
mi
from
Rochester, NY
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Finger Lakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Behavioral Medical Research of Staten Island
mi
from
Staten Island, NY
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Behavioral Medical Research of Staten Island
mi
from
Staten Island, NY
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Psychiatry and Behavioral Sciences, Duke
mi
from
Durham, NC
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Psychiatry and Behavioral Sciences, Duke
mi
from
Durham, NC
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Midwest Clinical Research Center
mi
from
Dayton, OH
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
CRI Worldwide - Kirkbride
mi
from
Philadelphia, PA
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
CRI Worldwide - Kirkbride
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Dept. of Psychiatry, UT Southwestern Medical Center
mi
from
Dallas, TX
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Dept. of Psychiatry, UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Grayline Clinical Drug Trials
mi
from
Wichita Falls, TX
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Grayline Clinical Drug Trials
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Synergy Clinical Research Center
mi
from
Escondido, CA
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Synergy Clinical Research Center
mi
from
Escondido, CA
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  3/10/2016
Florida Clinical Research Center, LLC
mi
from
Sarasota, FL
Major Depressive Disorder With Mixed Features - Extension
A 12-Week, Open-Label Extension Study For the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 3/10/2016
Florida Clinical Research Center, LLC
mi
from
Sarasota, FL
Click here to add this to my saved trials
Hepatitis C Translating Initiatives for Depression Into Effective Solutions
Hepatitis C Translating Initiatives for Depression Into Solutions
Status: Enrolling
Updated:  3/11/2016
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Hepatitis C Translating Initiatives for Depression Into Effective Solutions
Hepatitis C Translating Initiatives for Depression Into Solutions
Status: Enrolling
Updated: 3/11/2016
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
Hepatitis C Translating Initiatives for Depression Into Effective Solutions
Hepatitis C Translating Initiatives for Depression Into Solutions
Status: Enrolling
Updated:  3/11/2016
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
mi
from
St Louis, MO
Hepatitis C Translating Initiatives for Depression Into Effective Solutions
Hepatitis C Translating Initiatives for Depression Into Solutions
Status: Enrolling
Updated: 3/11/2016
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
mi
from
St Louis, MO
Click here to add this to my saved trials
Hepatitis C Translating Initiatives for Depression Into Effective Solutions
Hepatitis C Translating Initiatives for Depression Into Solutions
Status: Enrolling
Updated:  3/11/2016
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Hepatitis C Translating Initiatives for Depression Into Effective Solutions
Hepatitis C Translating Initiatives for Depression Into Solutions
Status: Enrolling
Updated: 3/11/2016
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Click here to add this to my saved trials
Hepatitis C Translating Initiatives for Depression Into Effective Solutions
Hepatitis C Translating Initiatives for Depression Into Solutions
Status: Enrolling
Updated:  3/11/2016
Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock
mi
from
Little Rock, AR
Hepatitis C Translating Initiatives for Depression Into Effective Solutions
Hepatitis C Translating Initiatives for Depression Into Solutions
Status: Enrolling
Updated: 3/11/2016
Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock
mi
from
Little Rock, AR
Click here to add this to my saved trials
Enhancing Parenting for Depressed Caregivers
Enhancing Parenting for Depressed Caregivers
Status: Enrolling
Updated:  3/11/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Enhancing Parenting for Depressed Caregivers
Enhancing Parenting for Depressed Caregivers
Status: Enrolling
Updated: 3/11/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain Function
Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain Function
Status: Enrolling
Updated:  3/14/2016
McLean Hospital
mi
from
Belmont, MA
Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain Function
Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain Function
Status: Enrolling
Updated: 3/14/2016
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery
Treatment of Depression Following Bypass Surgery
Status: Enrolling
Updated:  3/14/2016
University of Pittsburgh School of Medicine
mi
from
Pittsburgh, PA
Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery
Treatment of Depression Following Bypass Surgery
Status: Enrolling
Updated: 3/14/2016
University of Pittsburgh School of Medicine
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Woodland International Research Inc
mi
from
Little Rock, AR
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Woodland International Research Inc
mi
from
Little Rock, AR
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
South Coast Clinical Trials Inc.
mi
from
Anaheim, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
South Coast Clinical Trials Inc.
mi
from
Anaheim, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Catalina Research Institute
mi
from
Chino, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Catalina Research Institute
mi
from
Chino, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Clinical Innovations Inc.
mi
from
Riverside, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Clinical Innovations Inc.
mi
from
Riverside, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Synergy Escondido
mi
from
Escondido, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Synergy Escondido
mi
from
Escondido, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Florida Clinical Research Center LLC
mi
from
Maitland, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Florida Clinical Research Center LLC
mi
from
Maitland, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Excell Research, Inc.
mi
from
Oceanside, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Excell Research, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Sharp Mesa Vista Hospital
mi
from
San Diego, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Sharp Mesa Vista Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials